Viewing Study NCT04439305


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-05-17 @ 11:06 PM
Study NCT ID: NCT04439305
Status: WITHDRAWN
Last Update Posted: 2020-07-20
First Post: 2020-06-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X)
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Lymphoma View
None Advanced Malignant Solid Neoplasm View
None Hematopoietic and Lymphoid Cell Neoplasm View
None Refractory Lymphoma View
None Refractory Malignant Solid Neoplasm View
None Refractory Plasma Cell Myeloma View
Keywords: